Thrombotargets Europe SL
Castelldefels, Barcelona, Spain
Biotechnology company in Castelldefels
B 6, Mediterrani de la Tecnologia, Av. del Canal Olímpic, 08860 Castelldefels, Barcelona
About Thrombotargets Europe SL
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Thrombotargets Europe SL
During the past decade, Thrombotargets Europe SL conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
1995-11-01
1999-06-01
Completed
600
Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
1998-12-01
Unknown status
276
Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
1999-04-01
2011-07-01
Completed
4,590
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
1999-04-01
2011-02-01
Completed
605
A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer
2001-05-01
Completed
1,000
Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
2001-06-01
Completed
941
Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ
2003-09-01
2021-05-31
Completed
2,980
Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer
2003-09-01
2021-05-31
Completed
3,864
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Thrombotargets Europe SL
According to Clinical.Site data, the most researched conditions in "Thrombotargets Europe SL" are
"Degenerative Osteoarthritis" (1 trials) and "Tooth Extraction" (1 trials). Many other conditions were trialed in "Thrombotargets Europe SL" in a lesser frequency.
Clinical Trials Intervention Types at Thrombotargets Europe SL
Most popular intervention types in "Thrombotargets Europe SL" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "TT-173" (2 trials), "Placebo" (1 trials) and "placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Thrombotargets Europe SL
The vast majority of trials in "Thrombotargets Europe SL" are
2 trials for "All" genders.
Clinical Trials Status at Thrombotargets Europe SL
Currently, there are NaN active trials in "Thrombotargets Europe SL".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Thrombotargets Europe SL,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Thrombotargets Europe SL, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".